Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gladman DD (2002) Current concepts in psoriatic arthritis. Curr Opin Rheumatol 14: 361–366
Mease PJ (2003) Current treatment of psoriatic arthritis. Rheum Dis Clin N Am 29: 495–511
Krueger GG, et al. (1984) Psoriasis. J Am Acad Dermatol 11: 937–947
Wrone-Smith T, Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis [comment]. J Clin Invest 98: 1878–1887
Ellis CN, et al. (1991) Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial [see comment]. N Engl J Med 324: 277–284
Murphy FP, et al. (1999) Clinical clearing of psoriasis by 6-thioguanine correlates with cutaneous T-cell depletion via apoptosis: evidence for selective effects on activated T lymphocytes. Arch Dermatol 135: 1495–1502
Gottlieb SL, et al. (1995) Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Med 1: 442–447
Lebwohl M, et al. (2003) An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis [see comment]. Arch Dermatol 139: 719–727
Abrams JR, et al. (1999) CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest 103: 1243–1252
Pitzalis C, et al. (1996) Cutaneous lymphocyte antigen-positive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. Arthritis Rheum 39: 137–145
Tassiulas I, et al. (1999) Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis. Hum Immunol 60: 479–491
Borgato L, et al. (2002) The T cell receptor repertoire in psoriatic synovitis is restricted and T lymphocytes expressing the same TCR are present in joint and skin lesions. J Rheumatol 29: 1914–1919
Winchester R (2003) Psoriatic arthritis, dermatology in general medicine. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds) McGraw-Hill, New York, pp 428–429
Fyrand O (1979) Immunological studies on synovial joint membranes in psoriatic arthritis. Acta Derm Venereol Suppl 87: 15–20
Smith MD, et al. (1992) Immunohistochemical analysis of synovial membranes from inflammatory and non-inflammatory arthritides: scarcity of CD5 positive B cells and IL2 receptor bearing T cells. Pathology 24: 19–26
Veale D, et al. (1993) Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 36: 893–900
Costello PJ, et al. (2001) Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions appear antigen driven. J Immunol 166: 2878–2886
Curran SA, et al. (2004) Nucleotide sequencing of psoriatic arthritis tissue before and during methotrexate administration reveals a complex inflammatory T cell infiltrate with very few clones exhibiting features that suggest they drive the inflammatory process by recognizing autoantigens. J Immunol 172: 1935–1944
Fassbender HG, Fassbender R (1992) Synovial characteristics of seronegative spondarthritides. Clin Investigator 70: 706
Espinoza LR, et al. (1982) Vascular changes in psoriatic synovium. A light and electron microscopic study. Arthritis Rheum 25: 677–684
Reece RJ, et al. (1999) Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis Rheum 42: 1481–1484
Dupont E, et al. (1998) Antiangiogenic properties of a novel shark cartilage extract: potential role in the treatment of psoriasis. J Cutan Med Surg 2: 146–152
Fearon U, et al. (2003) Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 30: 260–268
Ritchlin C, et al. (1998) Patterns of cytokine production in psoriatic synovium. J Rheumatol 25: 1544–1552
Austin LM, et al. (1999) The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113: 752–759
Vervoordeldonk MJ, Tak PP (2002) Cytokines in rheumatoid arthritis. Curr Rheumatol Rep 4: 208–217
Danning CL, et al. (2000) Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum 43: 1244–1256
Vilcek J, Lee TH (1991) Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266: 7313–7316
Bazzoni F, Beutler B (1996) The tumor necrosis factor ligand and receptor families. N Engl J Med 334: 1717–1725
Brennan FM, Feldmann M (1992) Cytokines in autoimmunity. Curr Opin Immunol 4: 754–759
Saxne T, et al. (1988) Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 31: 1041–1045
Smith CA, et al. (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248: 1019–1023
Mohler KM, et al. (1993) Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151: 1548–1561
Sfikakis PP, Kollias G (2003) Tumor necrosis factor biology in experimental and clinical arthritis. Curr Opin Rheumatol 15: 380–386
Redlich K, et al. (2004) Overexpression of tumor necrosis factor causes bilateral sacroiliitis. Arthritis Rheum 50: 1001–1005
Baeten D, et al. (2001) Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study [comment]. Arthritis Rheum 44: 186–195
Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3: 55–78
Benjamin M, McGonagle D (2001) The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites. J Anat 199: 503–526
McGonagle D, et al. (1998) Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy [comment]. Arthritis Rheum 41: 694–700
Laloux L, et al. (2001) Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 60: 316–321
Marzo-Ortega H, et al. (2001) Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study [comment]. Arthritis Rheum 44: 2112–2117
Ribbens C, et al. (2002) Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis 61: 161–166
Vandooren B, et al. (2004) Matrix metalloproteinases and their inhibitors are involved in peripheral synovitis and downregulated by TNF blockade in spondyloarthropathy. Arthritis Rheum (in press)
Ritchlin CT, et al. (2003) Mechanisms of TNF-alpha and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 111: 821–831
Suda T, et al. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20: 345–357
Lacey DL, et al. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165–176
Hofbauer LC, Heufelder AE (2001) The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis. Arthritis Rheum 44: 253–259
Udagawa N, et al. (2002) The molecular mechanism of osteoclastogenesis in rheumatoid arthritis. Arthritis Res 4: 281–289
Braun J, et al. (1995) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38: 499–505
Peng H, et al. (2002) Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110: 751–759
Stankler L (1969) An experimental investigation on the site of skin damage inducing the Koebner reaction in psoriasis. Br J Dermatol 81: 534–535
Melski JW, Bernhard JD, Stern RS (1983) The Koebner (isomorphic) response in psoriasis. Associations with early age at onset and multiple previous therapies. Arch Dermatol 119: 655–659
Langevitz P, Buskila D, Gladman DD (1990) Psoriatic arthritis precipitated by physical trauma. J Rheumatol 17: 695–697
Rasmussen JE (2000) The relationship between infection with group A beta hemolytic streptococci and the development of psoriasis. Pediatr Infect Dis J 19: 153–154
Rahman MU, et al. (1990) High levels of antipeptidoglycan antibodies in psoriatic and other seronegative arthritides. J Rheumatol 17: 621–655
Vasey FB, et al. (1982) Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis. J Rheumatol 9: 719–722
Leung DY, et al. (1995) Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 96: 2106–2112
Travers JB, et al. (1999) Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis [comment]. J Clin Invest 104: 1181–1189
Arnett FC, Reveille JD, Duvic M (1991) Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection. Rheum Dis Clin North Am 17: 59–78
Brancato L, et al. (1989) Aspects of the spectrum, prevalence and disease susceptibility determinants of Reiter’s syndrome and related disorders associated with HIV infection. Rheumatol Int 9: 137–141
Mijiyawa M, Oniankitan O, Khan MA (2000) Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 12: 281–286
Njobvu P, McGill P (2000) Psoriatic arthritis and human immunodeficiency virus infection in Zambia. J Rheumatol 27: 1699–1702
Bardos T, et al. (2002) Mice lacking endogenous major histocompatibility complex class II develop arthritis resembling psoriatic arthritis at an advanced age. Arthritis Rheum 46: 2465–2475
Nickoloff BJ (2000) The search for pathogenic T cells and the genetic basis of psoriasis using a severe combined immunodeficient mouse model. Cutis 65: 110–114
Nickoloff BJ, Wrone-Smith T (1999) Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 155: 145–158
Hong K, et al. (1999) IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder. J Immunol 162: 7480–7491
Khare SD, Luthra HS, David CS (1995) Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J Exp Med 182: 1153–1158
Rothschild BM, Woods RJ (1989) Spondyloarthropathy in gorillas. Semin Arthritis Rheum 18: 267–276
Rothschild BM, Woods RJ (1992) Erosive arthritis and spondyloarthropathy in Old World primates. Am J Phys Anthropol 88: 389–400
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Barton, J., Ritchlin, C.T. (2005). Psoriatic Arthritis. In: Gordon, K.B., Ruderman, E.M. (eds) Psoriasis and Psoriatic Arthritis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27190-2_5
Download citation
DOI: https://doi.org/10.1007/3-540-27190-2_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21280-5
Online ISBN: 978-3-540-27190-1
eBook Packages: MedicineMedicine (R0)